Clinical Trial Update: A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apatinib plus concurrent neoadjuvant chemoradiotherapy for locally advanced HER-2 negative gastroesophageal junction adenocarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Hebei Medical University | Conditions: Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: UNKNOWN